KR20230004965A - 손상 조직의 재생 - Google Patents

손상 조직의 재생 Download PDF

Info

Publication number
KR20230004965A
KR20230004965A KR1020227045816A KR20227045816A KR20230004965A KR 20230004965 A KR20230004965 A KR 20230004965A KR 1020227045816 A KR1020227045816 A KR 1020227045816A KR 20227045816 A KR20227045816 A KR 20227045816A KR 20230004965 A KR20230004965 A KR 20230004965A
Authority
KR
South Korea
Prior art keywords
wound
tropelastin
tissue
epithelialization
edge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020227045816A
Other languages
English (en)
Korean (ko)
Inventor
안토니 스티븐 바이스
Original Assignee
앨러간 파마슈티컬스 인터내셔널 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903092A external-priority patent/AU2013903092A0/en
Application filed by 앨러간 파마슈티컬스 인터내셔널 리미티드 filed Critical 앨러간 파마슈티컬스 인터내셔널 리미티드
Publication of KR20230004965A publication Critical patent/KR20230004965A/ko
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A61F13/0203—Adhesive bandages or dressings with fluid retention members
    • A61F13/0213—Adhesive bandages or dressings with fluid retention members the fluid retention member being a layer of hydrocolloid, gel forming material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/06—Flowable or injectable implant compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
KR1020227045816A 2013-08-13 2014-08-13 손상 조직의 재생 Abandoned KR20230004965A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AU2013903092A AU2013903092A0 (en) 2013-08-13 Regeneration of damaged tissue
AU2013903092 2013-08-13
KR1020217040694A KR102488446B1 (ko) 2013-08-13 2014-08-13 손상 조직의 재생
PCT/AU2014/050180 WO2015021508A1 (en) 2013-08-13 2014-08-13 Regeneration of damaged tissue

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020217040694A Division KR102488446B1 (ko) 2013-08-13 2014-08-13 손상 조직의 재생

Publications (1)

Publication Number Publication Date
KR20230004965A true KR20230004965A (ko) 2023-01-06

Family

ID=52467858

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020227045816A Abandoned KR20230004965A (ko) 2013-08-13 2014-08-13 손상 조직의 재생
KR1020217040694A Active KR102488446B1 (ko) 2013-08-13 2014-08-13 손상 조직의 재생
KR1020167005263A Ceased KR20160041949A (ko) 2013-08-13 2014-08-13 손상 조직의 재생

Family Applications After (2)

Application Number Title Priority Date Filing Date
KR1020217040694A Active KR102488446B1 (ko) 2013-08-13 2014-08-13 손상 조직의 재생
KR1020167005263A Ceased KR20160041949A (ko) 2013-08-13 2014-08-13 손상 조직의 재생

Country Status (12)

Country Link
US (4) US20160194379A1 (https=)
EP (2) EP4316537A3 (https=)
JP (3) JP6382311B2 (https=)
KR (3) KR20230004965A (https=)
CN (2) CN105530951B (https=)
AU (3) AU2014306362B2 (https=)
BR (1) BR112016003082A8 (https=)
CA (1) CA2920312C (https=)
ES (1) ES2965893T3 (https=)
MX (2) MX377200B (https=)
RU (1) RU2677637C2 (https=)
WO (1) WO2015021508A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014063194A1 (en) 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
ES2860023T3 (es) 2012-12-10 2021-10-04 Allergan Pharmaceuticals Int Ltd Fabricación de constructos elásticos tridimensionales escalables
KR20230004965A (ko) * 2013-08-13 2023-01-06 앨러간 파마슈티컬스 인터내셔널 리미티드 손상 조직의 재생
CA2996427A1 (en) * 2015-09-01 2017-03-09 Allergan Pharmaceuticals International Limited Formation of bone
EP3534982A4 (en) * 2016-11-04 2020-06-10 Allergan Pharmaceuticals International Limited BIOSYNTHETIC DEVICES
WO2020225694A1 (en) * 2019-05-03 2020-11-12 Allergan Pharmaceuticals International Limited Scar prevention and/or treatment
US20230310552A1 (en) * 2020-09-08 2023-10-05 Protein Genomics Inc. Biomimetic wound healing devices and related methods of treating diabetic wounds

Family Cites Families (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675387A (en) 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
US5260203A (en) 1986-09-02 1993-11-09 Enzon, Inc. Single polypeptide chain binding molecules
US4947840A (en) 1987-08-21 1990-08-14 Massachusetts Institute Of Technology Biodegradable templates for the regeneration of tissues
EP0368684B2 (en) 1988-11-11 2004-09-29 Medical Research Council Cloning immunoglobulin variable domain sequences.
AU645794B2 (en) 1990-03-30 1994-01-27 Shiseido Company Ltd. Process for purifying polypeptide
US5844094A (en) 1992-09-25 1998-12-01 Commonwealth Scientific And Industrial Research Organization Target binding polypeptide
AU688746B2 (en) * 1992-12-22 1998-03-19 University Of Sydney, The Synthetic polynucleotides
US5726040A (en) 1993-11-10 1998-03-10 Ensley; Burt D. Cosmetic compositions including tropoelastin isomorphs
US7001328B1 (en) 1994-11-15 2006-02-21 Kenton W. Gregory Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO591797A0 (en) 1997-03-27 1997-04-24 Commonwealth Scientific And Industrial Research Organisation High avidity polyvalent and polyspecific reagents
JP2001505539A (ja) 1996-08-07 2001-04-24 プロテイン・スペシャルティーズ，リミテッド エラスチン及び他の線維状タンパク質由来の自己整列ペプチド
AUPO156596A0 (en) * 1996-08-09 1996-09-05 University Of Sydney, The Synthetic polynucleotides
CA2279902C (en) 1997-02-07 2009-01-13 Sisters Of Providence In Oregon Method for using tropoelastin and for producing tropoelastin biomaterials
AUPO811797A0 (en) 1997-07-18 1997-08-14 University Of Sydney, The Tropoelastin derivatives
AU9313298A (en) 1997-09-04 1999-03-22 Point Biomedical Corporation Injectable tissue reconstruction material
AUPP472398A0 (en) 1998-07-17 1998-08-13 University Of Sydney, The Protease susceptibility II
US20030009013A1 (en) 1998-12-30 2003-01-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
CA2383539C (en) * 1999-05-28 2007-12-04 Kenton W. Gregory Methods for producing laminated elastin, elastin-based materials and tropoelastin products for repairing and/or replacing tissue
DK1229940T3 (da) 1999-11-15 2014-08-18 Piramal Healthcare Canada Ltd Temperaturstyret og ph-afhængig selvgelerende, vandig biopolymeropløsning
US20050244393A1 (en) 1999-12-22 2005-11-03 Henogen S.A. Sealant or tissue generating product
US6808707B2 (en) * 2000-02-04 2004-10-26 Matrix Design Wound healing compositions and methods using tropoelastin and lysyl oxidase
US20040110439A1 (en) 2001-04-20 2004-06-10 Chaikof Elliot L Native protein mimetic fibers, fiber networks and fabrics for medical use
US7125960B2 (en) 2001-05-30 2006-10-24 Chisso Corporation Crosslinked elastin and process for producing the same
AU2002952492A0 (en) 2002-11-06 2002-11-21 Cbio Limited Chaperonin 10 immunosuppression
US8383158B2 (en) 2003-04-15 2013-02-26 Abbott Cardiovascular Systems Inc. Methods and compositions to treat myocardial conditions
US8038991B1 (en) 2003-04-15 2011-10-18 Abbott Cardiovascular Systems Inc. High-viscosity hyaluronic acid compositions to treat myocardial conditions
FR2855968B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de la synthese et de l'activite d'une isoforme de la lysyl oxydase-like loxl pour stimuler la formation de fibres elastiques
FR2855969B1 (fr) 2003-06-13 2012-11-30 Coletica Stimulation de l'activite d'une isoforme de lysyl oxydase pour lutter contre certaines pathologies dues a une elastogenese incomplete, absente ou desorganisee
US8226715B2 (en) 2003-06-30 2012-07-24 Depuy Mitek, Inc. Scaffold for connective tissue repair
CA2562871C (en) 2004-02-20 2014-06-10 Human Matrix Sciences, Llc Iron based compounds for elastogenesis and connective tissue treatment
US7192043B1 (en) 2004-05-25 2007-03-20 Mcluen Design, Inc. Multi-terrain wheel chair
US7968085B2 (en) 2004-07-05 2011-06-28 Ascendis Pharma A/S Hydrogel formulations
US20060062768A1 (en) 2004-09-23 2006-03-23 Olexander Hnojewyj Biocompatible hydrogel compositions
WO2006098024A1 (ja) 2005-03-16 2006-09-21 Fujitsu Limited Ipネットワークにおけるマルチキャストツリー監視方法およびシステム
EP1863829A2 (en) 2005-03-24 2007-12-12 Straumann Holding AG Method for protein purification comprising heat incubation in acetic acidic solution
US8828433B2 (en) 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
KR100785378B1 (ko) 2005-09-05 2007-12-14 주식회사 바이오레인 다층구조의 유착방지제
EP1945144A4 (en) 2005-10-19 2012-12-05 Kenton W Gregory PROCESS FOR THE USE AND PRODUCTION OF TROPOELASTIN AND BIOMATERIALS BASED ON TROPOELASTIN
US7770126B2 (en) 2006-02-10 2010-08-03 Microsoft Corporation Assisting user interface element use
US8518105B2 (en) 2006-03-24 2013-08-27 Abbott Cardiovascular System Inc. Methods and apparatuses for coating a lesion
US20070237735A1 (en) 2006-03-31 2007-10-11 Laboratoires Dermo-Cosmetik Inc. Anti-aging composition, kit and method of use
EP2101724B1 (en) 2006-05-11 2020-12-02 Regenics AS Administration of cellular extracts for rejuvenation
US20070287741A1 (en) 2006-06-13 2007-12-13 Uri Herzberg Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals
WO2008033847A2 (en) 2006-09-11 2008-03-20 Emory University Modified protein polymers
EP2117620A4 (en) 2006-09-29 2010-12-01 Martin Kean Chong Ng PROTOELASTINE BIOMATERIALS FROM TROOELASTINE
WO2008058323A1 (en) * 2006-11-13 2008-05-22 The University Of Sydney Use of tropoelastin for repair or restoration of tissue
US20090136438A1 (en) * 2007-07-25 2009-05-28 Dermaplus, Inc. Photo-protective dermatological formulations and methods of using the same
US8455459B2 (en) 2007-08-02 2013-06-04 Medicis Pharmaceutical Corporation Method of applying an injectable filler
FR2920968B1 (fr) 2007-09-14 2009-11-13 Oreal Procede cosmetique de traitement esthetique et/ou reparateur de la peau
US9421305B2 (en) 2008-02-01 2016-08-23 Wake Forest University Health Sciences Aligned scaffolding system for skeletal muscle regeneration
US8469961B2 (en) 2008-03-05 2013-06-25 Neville Alleyne Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints
US8940331B2 (en) 2008-11-22 2015-01-27 The Board Of Trustees Of The Leland Stanford Junior University Hydrogels, methods of making hydrogels, methods of using hydrogels, and methods of isolating, trapping, attracting, and/or killing cancer cells
US8080265B2 (en) 2009-02-20 2011-12-20 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating signs of skin aging
JP5684154B2 (ja) * 2009-03-10 2015-03-11 ザ・ユニバーシティ・オブ・シドニー 注射用生体材料
ES2585388T5 (es) 2010-03-22 2019-08-08 Allergan Inc Hidrogeles reticulados de polisacárido y proteína-polisacárido para aumento de tejido blando
WO2011127478A1 (en) 2010-04-09 2011-10-13 Nanovasc, Inc. Sleeve for graft and method
US8658711B2 (en) 2010-09-29 2014-02-25 Rutgers, The State University Of New Jersey Process for the synthesis of methacrylate-derivatized type-1 collagen and derivatives thereof
DK2643029T3 (da) 2010-11-23 2019-05-06 Allergan Pharmaceuticals Int Ltd Præparat og/eller formulering af proteiner, som er tværbundet med polysaccharider
GB201021438D0 (en) 2010-12-16 2011-02-02 Imp Innovations Ltd Layered fibrous construct
US9114128B2 (en) 2011-09-30 2015-08-25 Protein Genomics, Inc. Tropoelastins and uses thereof
BR112014007451A2 (pt) * 2011-09-30 2017-04-04 Univ Sydney síntese in vivo de fibras elásticas
WO2014063194A1 (en) * 2012-10-23 2014-05-01 The University Of Sydney Elastic hydrogel
ES2860023T3 (es) 2012-12-10 2021-10-04 Allergan Pharmaceuticals Int Ltd Fabricación de constructos elásticos tridimensionales escalables
KR20230004965A (ko) * 2013-08-13 2023-01-06 앨러간 파마슈티컬스 인터내셔널 리미티드 손상 조직의 재생
KR20160055940A (ko) 2013-09-24 2016-05-18 엘라스타겐 피티와이 리미티드 단백질 추출 방법

Also Published As

Publication number Publication date
US20160194379A1 (en) 2016-07-07
JP2020049282A (ja) 2020-04-02
CA2920312C (en) 2022-07-19
AU2019204972B2 (en) 2021-07-08
US20220098281A1 (en) 2022-03-31
AU2021245202B2 (en) 2025-01-23
KR20210154881A (ko) 2021-12-21
RU2016104618A (ru) 2017-09-14
RU2677637C2 (ru) 2019-01-18
MX377200B (es) 2025-03-07
JP2016527979A (ja) 2016-09-15
EP3033099A1 (en) 2016-06-22
CA2920312A1 (en) 2015-02-19
AU2014306362A1 (en) 2016-02-18
CN110464837A (zh) 2019-11-19
KR102488446B1 (ko) 2023-01-13
CN105530951B (zh) 2019-10-22
JP6891257B2 (ja) 2021-06-18
MX2016001436A (es) 2016-07-05
AU2014306362B2 (en) 2019-04-18
EP3033099B1 (en) 2023-11-01
CN105530951A (zh) 2016-04-27
RU2016104618A3 (https=) 2018-06-18
US20250171522A1 (en) 2025-05-29
AU2019204972A1 (en) 2019-08-01
WO2015021508A1 (en) 2015-02-19
JP2018164789A (ja) 2018-10-25
MX2020011880A (es) 2021-01-20
EP4316537A3 (en) 2024-04-10
US11084867B2 (en) 2021-08-10
EP4316537A2 (en) 2024-02-07
AU2021245202A1 (en) 2021-11-04
JP6639587B2 (ja) 2020-02-05
US20190062405A1 (en) 2019-02-28
BR112016003082A2 (pt) 2017-08-01
ES2965893T3 (es) 2024-04-17
EP3033099A4 (en) 2017-04-12
BR112016003082A8 (pt) 2020-01-28
JP6382311B2 (ja) 2018-08-29
KR20160041949A (ko) 2016-04-18

Similar Documents

Publication Publication Date Title
US20250171522A1 (en) Regeneration of damaged tissue
Lorenz et al. Wounds: biology, pathology, and management
De Vries et al. Dermal regeneration in native non‐cross‐linked collagen sponges with different extracellular matrix molecules
Yao et al. Promotion of collagen deposition during skin healing through Smad3/mTOR pathway by parathyroid hormone-loaded microneedle
US12178940B2 (en) Controlled hydrogel delivery of focal adhesion kinase inhibitor for decreased scar formation
US20240293596A1 (en) Compositions and methods for treating wounds
JP2019511468A (ja) 慢性創傷を治療するための組成物及び方法
Litvinova et al. Problems of healing soft tissue injuries
HK40016252A (zh) 受损组织的再生
Nath A Clinical Study on the Efficacy of Autologous Platelet Rich Plasma in the Management of Chronic Non Healing Ulcers
Smith et al. Therapeutic Approaches to Treat Hypertrophic Scars
Lorenz et al. Wounds: Biology
Hrynyk Enhanced burn wound healing through controlled and sustained delivery of bioactive insulin from alginate sponge dressings
최진일 Assessment of Wound Healing Efficacy of Porcine Placental Amniotic Membrane Derived Extracellular Matrix
Lorenz et al. Wounds: Biology, Pathology, and
Charles et al. 19 Active Treatments for
CHERRY et al. HEALING PHASES

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PC1904 Unpaid initial registration fee

St.27 status event code: A-2-2-U10-U14-oth-PC1904

St.27 status event code: N-2-6-B10-B12-nap-PC1904